GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines

The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia.

Scroll to Top